Biotron is preparing a ***detailed briefing package to submit to the FDA during the first quarter of 2022.
Guidance from the FDA will inform the final design of a suitable international trial and will be a key
component of outreach to **potential partners.
**potential partners are what they have been ....
*** they're preparing detailed package in that they're confident to move forward with FDA guidance...
Biotron's Phenomenal Success ..., page-3
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $2.393K | 44.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19600 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 188178 | 2 |
View Market Depth
| Last trade - 15.15pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.4¢ | 5.2¢ | 120722 | ||
| Last updated 15.15pm 03/05/2024 ? | |||||
| BIT (ASX) Chart |